Malaria is a global health problem, affecting millions of people annually. According to the World Malaria Report 2015, there were 214 million new cases of malaria globally (range 149 -303 million) with an estimated mortality of 438,000 (range 236,000 -635,000). The vast majority of the cases occur in the WHO African Region (88%), with the rest being in the WHO South East Asian Region (10%) and the WHO Eastern Mediterranean Region (2%). Malaysia is experiencing sporadic outbreaks of malaria due to influx of foreign workers from neighboring countries and failure to take antimalarial prophylaxis amongst travellers. The aim of the review is to increase the awareness among the healthcare professionals on the increasing prevalence of malaria especially among migrant workers. Currently our health screening program for migrant workers does not include screening for malaria.
Introduction
A decade ago, the incidence of malaria was estimated to be 262 million in the year 2000 with 839,000 deaths. With continuous effort from World Health Organization and local government, the annual incidence rate and mortality rate have decreased by 37% and 48% respectively between 2000 and 2015 [1] .
Malaysia has made great progress in the control of malaria as shown in the decrease of incidence rate (per 100,000 population) of 37.0 in 2001 to 14.7 in
Plasmodium Species
The causative agent of malaria is Plasmodium parasites, which are transmitted to human through bites of infected female Anopheles mosquitoes. There are five parasite species that infect human, namely P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi. Among them, P. falciparum and P. vivax are the most common parasites with P. falciparum being dominant in Africa and P. vivax in most countries outside of sub-Saharan Africa [5] . Before the first naturally acquired P. knowlesi infection in humans was reported in 1965, P. knowlesi is only found in macaque monkeys [6] . P. malariae and P. knowlesi are difficult to distinguish microscopically, leading to misdiagnosis and classification as a single group for notification of cases [7] [8].
P. falciparum used to be the most prevalent parasite in Malaysia but there was a declining trend in P. falciparum cases from 1997 to 2011. As of 2011, P. vivax accounted for almost half of the causative parasite (2 422 cases, 45.6%), followed by P. falciparum (973 cases, 18.3%), P. malariae (903 cases, 17.0%) and P. knowlesi (854 cases, 16 .1%) (Figure 3 ) [3] . However, Figure 4 shows there are concerns of increasing reported cases of P. knowlesi in Malaysia since year 2008, making it the country with highest proportion of P. knowlesi in WHO Western Pacific Region [1] . According to retrospective review of Sabah Department of Health malaria notification data from 1992-2013, the percentage of malaria cases in Sabah caused by P. malariae/P. knowlesi was on the increasing trend from 1% in 1992 to 35% in 2011 and to 62% in 2013 [8] [9] .
Parasite Life Cycle
Malaria parasite is transmitted by a vector, which is female Anopheles mosquito.
The disease-causing vectors vary according to geographical location. In Malaysia, An. maculates, An. balabacensis, An. dirus, An. letifer, An. camperstris, An.
sundaicus, An donaldi, An. leucophyrus and An. flavirostris are the common Anopheles species responsible as vector [10] . The basic life cycle of malaria parasites comprises sexual phase in the mosquitoes and asexual phase in human. 
Risk Factors
The transmission of malaria is affected by a number of environmental, socio-demographic, economic and human factors. For environmental factors, malaria prevalence is positively associated with increased in rainfall and living in areas Figure 5 illustrates the life cycle of malaria (No 1 -12) as described below. The infected female anopheles mosquito takes a blood meal (1) and injects the sporozoites into the human blood stream. The sporozoites, in turn, go on to infect the liver cells and proliferate of which some may become dormant to cause relapse later. After multiplication in the liver cells, schizonts will form and the rupture of the liver cells releases merozoites into the blood stream. Now the erythrocytic stage begins. There are various stages in the red blood cell like the ring form, immature trophozoites, mature trophozoites, schizonts, rupture of red blood cells and further repetition of cycle in new red blood cells. Some of the trophozoites may develop into the male and female gametocytes which the anopheles mosquito takes up during the blood meal beginning the sporogonic life cycle in the mosquito resulting in trophozoite formation to infect more humans. The sporogonic cycle takes place in the mosquito. The male and female gametocytes develop into mature gametes and with fusion, the zygote forms. The zygote elongates into ookinetes which move through the stomach wall. The ookinetes develop into oocyts. The oocyts grow and rupture releasing sporozoites. The sprorozoites migrate into the salivary glands and is ready to begin a new cycle in the human following a mosquito bite. where stream or stagnant water existed because water provides a good breeding ground for the Anopheles mosquitoes [14] [15] [16] . Global warming also has an effect on the spread of malaria as places that are formerly too cold to support malaria are now susceptible to the vectors [17] .
Socioeconomic risk factors are involved in transmission of malaria as low household income is often associated to poor housing conditions, overcrowding and living in rural areas [18] [19] . Urbanization also contributes to transmission of malaria due to high rate of construction which leads to improper water drai- such as staying in rooms with air-conditioning, using screens, bed nets, repellents, insecticides and wearing clothing that cover exposed parts of the body at dawn or dusk. Among the PPMs, staying in air-conditioned rooms and covering arms and legs were effective while the use of repellants and insecticides did not show significant protection [25] . A meta-analysis proved that chemoprophylaxis with atovaquone-proguanil has prophylaxis efficacy of 95.8% compared to placebo and was well tolerated [26] . A Cochrane review on the effectiveness of insecticide-treated nets (ITNs) in prevention of malaria showed that the use of
ITNs reduced the incidence of uncomplicated malarial episodes by 50% and 62%
in areas of stable and unstable malaria respectively. On top of that, ITNs also conferred benefits in areas of stable malaria by providing protection against severe malaria, parasitaemia, splenomegaly and anaemia [27] .
Clinical Presentations
Uncomplicated malaria is usually associated with influenza-like symptoms such as fever, chills, sweats, headaches, nausea and vomiting, body aches and general malaise [28] . The frequencies of the common complaints as investigated in Northeastern Indonesian Papua were as follows: fever (87%), vomiting (55%), nausea (22%), headache (18%), chills (16%), malaise (11%), and vertigo (11%) [29] . Severe malaria often leads to poor clinical outcomes. The case fatality rate in travelers with severe malaria caused by P. falciparum can be higher than 20% [30] . The criteria for severe malaria established by WHO (revised in 2000) which are used to assist clinical and epidemiological studies are as follows: impaired consciousness (Glasgow Coma Score < 11 in adults or Blantyre coma score < 3 in children), acidosis (base deficit of >8 meq/l or plasma bicarbonate of <15 mM or lactate > 5 mM), hypoglycaemia (plasma glucose < 2.2 mM), severe malarial anaemia (haemoglobin concentration < 5 g/dl with parasite count > 10,000/µl), renal impairment (serum creatinine > 265 µM or blood urea > 20 mM), jaundice (serum bilirubin > 50 µM), pulmonary oedema (Radiologically confirmed, or oxygen saturation < 92% on room air with a respiratory rate > 30/min), significant bleeding, shock and hyperparasitaemia (P. falciparum parasitaemia > 10%) [31] . The manifestations of severe malaria differ according to age of patient: in children under 2 years old, severe anaemia predominates; in older children, seizure and cerebral malaria are more frequent; whereas in adults, acute renal failure, acute pulmonary oedema, liver dysfunction, and cerebral malaria are all possible [32] . 
Factors Influencing Clinical Outcomes
Several factors contribute to the poor prognosis of severe malaria such as the infecting malaria parasite species, the degree of abnormality, the number of systems affected, coexisting medical conditions, no antimalarial prophylaxis, delay in treatment, age, gender (especially when associated with pregnancy) and background immunity (nonimmune status) [30] [31]. P. knowlesi infections lead to the highest mortality rate, followed by those caused by P. falciparum [31] . In areas where malaria is endemic, approximately 70% of deaths occur in children age under 5 due to the lack of protective semi-immune status which is likely to be acquired after repeated bouts of infections [34] . Base deficit, impaired consciousness, convulsions, elevated blood urea, and underlying chronic illness were identified as the key prognostic indicators in children [35] . In non-endemic area, population generally lacks protective immunity and case fatality rate is almost 6 times greater among elderly patients [36] .
Diagnosis
Diagnosis of malaria is based on clinical suspicion and parasitological confirmation (detection of parasites in the blood). In countries where malaria is endemic but access to laboratory confirmation is severely limited such as in most of Africa south of the Sahara, probable or suspected cases are defined as diagnosis and treatment of malaria based on clinical presentations. The diagnosis is based on patients' signs and symptoms and physical findings such as fever, headache, weakness, myalgia, chills, dizziness, abdominal pain, diarrhoea, nausea, vomiting and pruritus [37] . However, these clinical presentations are non-specific and overlap with other common diseases, making clinical diagnosis less sensitive and specific. Studies had shown that malaria is overly treated in most malaria endemic areas, where only less than half of patients with suspected malaria infection are truly infected with a malaria parasite. es with microscopic appearance of P. malariae due to its high cost of labour and reagents and long processing time [38] . RDT, also known as immunochromatographic test, functions by detecting parasite antigens in the blood and is useful in patients with negative results from blood films due to incomplete antimalarial treatment [39] . Current RDTs on the market detect antigens namely histidine-rich protein 2 (HRP2), various subtypes of Plasmodium lactate dehydrogenase (pLDH), and aldolase in various combinations. Thus, selection of RDTs will be dependent on the species of parasite present in the particular region [40] . The test can provide results within 2 -15 minutes but lack sensitivity and ability to quantify the parasites [41] . Besides that, it is sensitive to heat and humidity, making storage and transport inconvenient [42] .
Diagnostic Challenges
In non-endemic regions, diagnosis can be challenging due to low parasite density which might lead to false negative results by RDT, altered parasite morphology due to consumption of chemoprophylaxis and inexperienced lab technicians in differentiating malaria species [42] . In malaria endemic regions such as Africa, fever and septic shock are frequently misdiagnosed as severe malaria, leading to failure to treat the true underlying infections. Even in symptomatic individuals, parasitaemia might not be the definitive diagnosis of malaria because it can be incidental to other concurrent diseases [42] [43] . In these areas, children un-Open Access Library Journal penditure and contributing to the spread of drug resistance [44] .
Co-Infection
Another mosquito-borne infection that causes high morbidity and mortality rate in tropical countries is dengue. Retrospective study involving 1723 febrile patients in French Guiana found that the rate of dengue-malaria co-infection was 0.99% whereas a cross-sectional study in the Brazilian Amazon involving 1578 subjects showed a higher rate of 2.8% [45] [46] . It is interesting to note that despite the high incidence rate of dengue and malaria in South East Asia, concurrent malaria and dengue infections are rarely reported [47] . In a study involving 194 patients with dengue in Thailand, no co-infection with malaria was detected whereas another study involving 1723 consecutive febrile patients in French (2016) showed that in the past decades, there were 36 reported incidences of dengue-malaria co-infection in Asia, of which majority (26 cases) were from India. In Malaysia, there is only one case report of patient co-infected with malaria, dengue and leptospirosis [50] . No study has been published to investigate the lower rate of dengue malaria co-infection in Asia thus far.
Treatment
According to Ministry Of Health Malaysia (2013), the preferred treatment for patient with uncomplicated P. falciparum, P. malariae and P. knowlesi is artemisinin-based combination therapies (ACT), which include regime of artemether and lumefantrine for 3 days or artesunate and doxycycline for 7 days for severe cases. For uncomplicated P. vivax and P. ovale infection, chloroquine is recommended but ACT should be used in chloroquine-resistant infections. Primaquine is given for 14 days to prevent relapse of the infection.
Of the five species of plasmodium that infect human, P. falciparum and P. vivax have been reported to be resistant to antimalarial drugs [51] . Researchers found that resistance commonly develops within 10 -15 years after an antimalarial is introduced [52] . Since 1946, chloroquine (CQ) has been used as the drug of choice for uncomplicated falciparum malaria until 1950s when drug resistance was reported and reduced its usefulness [53] . Depending on geographical location, P. falciparum has developed resistance to nearly all anti-malarials in current use such as chloroquine, sulfadoxine-pyrimethamine (SP) and mefloquine (MEF) whereas P. vivax is reported to be resistant to CQ and primaquine [51] . Resistance occurs when the parasites undergo spontaneous single or multiple point mutations which makes them less sensitive to anti-malarial drugs. For instance, P. falciparum develops resistance towards CQ via its increased capacity to expel chloroquine to prevent it from inhibiting its haem polymerisation process [51] . Cross resistance may occur to the other quinoline antimalarials The program focuses on five strategies namely: i) stopping the spread of resistant parasites; ii) strengthening surveillance to evaluate the threat of artemisinin resistance; iii) improvement of access to diagnostics and rational treatment with ACTs; iv) investment in artemisinin resistance-related research; and v) motivating action and mobilizing resources [57] .
Malaysia is vulnerable to having CQ-resistant P. vivax strain due to the frequent of mobilisation of people between neighbouring countries with high grade 
Malaria Surveillance
The majority of malaria cases in Malaysia are found through passive case detection Figure 6 . Distribution of confirmed foci and areas of anti-malarial resistant of P. falciparum malaria in South East Asia [54] . In Malaysia, a number of outbreaks were due to imported cases such as the outbreak in Tanjung Bungah, Penang in April 2006 of which 56 of the 58 positive cases involved foreign workers with majority from Indonesia. Following the outbreak, 187 medicated mosquito nets were distributed, 54 focal spraying and 9118 fogging exercises were conducted along with talks, dialogues and distribution posters and pamphlets to stop further transmission of the outbreak [62] . Another outbreak in April 2007 which affected 61 people from seven villages in Lawin, Gerik, Ipoh was attributed to infected Thai rubber tappers in the area [63] . According to CDC outbreak guideline, measures to prevent further transmission during an outbreak include vector management, health promotion to educate public on protective behaviours, active case finding, identify vulnerable groups using community mapping, provide insecticide treated nets and mosquito repellent, and other control measures [64] . Malaysia has included "preparedness and outbreak response" as one of the seven strategies in the National Strategic Planning for elimination of malaria (2011-2020) with the aim to allow early detection of outbreak and control it within 6 weeks [4] . Malaysia has also been collaborating with private sectors such as plantation companies since 1990s as one of the efforts to eliminate malaria. Such partnerships have brought great success in accessing the high-risk population [4] [65] .
